Correlation Between Spero Therapeutics and RAPT Therapeutics
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and RAPT Therapeutics, you can compare the effects of market volatilities on Spero Therapeutics and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and RAPT Therapeutics.
Diversification Opportunities for Spero Therapeutics and RAPT Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Spero and RAPT is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and RAPT Therapeutics go up and down completely randomly.
Pair Corralation between Spero Therapeutics and RAPT Therapeutics
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the RAPT Therapeutics. In addition to that, Spero Therapeutics is 1.57 times more volatile than RAPT Therapeutics. It trades about -0.05 of its total potential returns per unit of risk. RAPT Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 116.00 in RAPT Therapeutics on November 28, 2024 and sell it today you would lose (1.00) from holding RAPT Therapeutics or give up 0.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. RAPT Therapeutics
Performance |
| Timeline |
| Spero Therapeutics |
| RAPT Therapeutics |
Spero Therapeutics and RAPT Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and RAPT Therapeutics
The main advantage of trading using opposite Spero Therapeutics and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
| RAPT Therapeutics vs. Connect Biopharma Holdings | RAPT Therapeutics vs. Tyra Biosciences | RAPT Therapeutics vs. Xilio Development | RAPT Therapeutics vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |